397 related articles for article (PubMed ID: 35528183)
21. Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Krüppel-like factor 3 (KLF3) promotes osteosarcoma progression.
Shan HJ; Gu WX; Duan G; Chen HL
Bioengineered; 2022 Apr; 13(4):8038-8050. PubMed ID: 35311620
[TBL] [Abstract][Full Text] [Related]
22. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
Song W; Yang K; Luo J; Gao Z; Gao Y
Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
[TBL] [Abstract][Full Text] [Related]
23. Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis.
Li L; Zang L; Zhang F; Chen J; Shen H; Shu L; Liang F; Feng C; Chen D; Tao H; Xu T; Li Z; Kang Y; Wu H; Tang L; Zhang P; Jin P; Shu Q; Li X
Hum Mol Genet; 2017 Jul; 26(13):2398-2411. PubMed ID: 28398475
[TBL] [Abstract][Full Text] [Related]
24. Fat mass and obesity-associated factor (FTO)-mediated N6-methyladenosine regulates spermatogenesis in an age-dependent manner.
Wu Y; Li J; Li C; Lu S; Wei X; Li Y; Xia W; Qian C; Wang Z; Liu M; Gu Y; Huang B; Tan Y; Hu Z
J Biol Chem; 2023 Jun; 299(6):104783. PubMed ID: 37146971
[TBL] [Abstract][Full Text] [Related]
25. Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases.
You Y; Fu Y; Huang M; Shen D; Zhao B; Liu H; Zheng Y; Huang L
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628623
[TBL] [Abstract][Full Text] [Related]
26. m
Onalan E; Yakar B; Onalan EE; Karakulak K; Kaymaz T; Donder E
J Coll Physicians Surg Pak; 2022 Sep; 32(9):1143-1148. PubMed ID: 36089710
[TBL] [Abstract][Full Text] [Related]
27. FTO in cancer: functions, molecular mechanisms, and therapeutic implications.
Li Y; Su R; Deng X; Chen Y; Chen J
Trends Cancer; 2022 Jul; 8(7):598-614. PubMed ID: 35346615
[TBL] [Abstract][Full Text] [Related]
28. N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3'-end processing.
Bartosovic M; Molares HC; Gregorova P; Hrossova D; Kudla G; Vanacova S
Nucleic Acids Res; 2017 Nov; 45(19):11356-11370. PubMed ID: 28977517
[TBL] [Abstract][Full Text] [Related]
29. Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes.
Yang Y; Shen F; Huang W; Qin S; Huang JT; Sergi C; Yuan BF; Liu SM
J Clin Endocrinol Metab; 2019 Mar; 104(3):665-673. PubMed ID: 30137347
[TBL] [Abstract][Full Text] [Related]
30. The Role of FTO in Tumors and Its Research Progress.
Wei H; Li Z; Liu F; Wang Y; Ding S; Chen Y; Liu J
Curr Med Chem; 2022; 29(5):924-933. PubMed ID: 34269659
[TBL] [Abstract][Full Text] [Related]
31. N6-methyladenosine demethylase FTO impairs hepatic ischemia-reperfusion injury via inhibiting Drp1-mediated mitochondrial fragmentation.
Du YD; Guo WY; Han CH; Wang Y; Chen XS; Li DW; Liu JL; Zhang M; Zhu N; Wang X
Cell Death Dis; 2021 May; 12(5):442. PubMed ID: 33947842
[TBL] [Abstract][Full Text] [Related]
32. N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1α signalling axis.
Zhuang C; Zhuang C; Luo X; Huang X; Yao L; Li J; Li Y; Xiong T; Ye J; Zhang F; Gui Y
J Cell Mol Med; 2019 Mar; 23(3):2163-2173. PubMed ID: 30648791
[TBL] [Abstract][Full Text] [Related]
33. FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner.
Sun Z; Sun X; Qin G; Li Y; Zhou G; Jiang X
Epigenetics; 2023 Dec; 18(1):2242688. PubMed ID: 37538000
[TBL] [Abstract][Full Text] [Related]
34. m
Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y
Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060
[TBL] [Abstract][Full Text] [Related]
35. m
Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
[TBL] [Abstract][Full Text] [Related]
36. FTO knockdown alleviates hypoxia-induced PC12 cell injury by stabilizing GADD45B in an IGF2BP2-dependent manner.
Wang D; Li Y; Xu X; Zhao S; Wang Z; Yang J; Zhang X; Pan J; Wang Y; Liu M
Biochem Biophys Res Commun; 2022 Sep; 619():166-172. PubMed ID: 35803057
[TBL] [Abstract][Full Text] [Related]
37. N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells.
Tang S; Meng J; Tan J; Liu X; Zhou H; Li N; Hou S
Clin Immunol; 2022 Aug; 241():109080. PubMed ID: 35878734
[TBL] [Abstract][Full Text] [Related]
38. Regulation of N6-Methyladenosine after Myocardial Infarction.
Vausort M; Niedolistek M; Lumley AI; Oknińska M; Paterek A; Mączewski M; Dong X; Jäger C; Linster CL; Leszek P; Devaux Y
Cells; 2022 Jul; 11(15):. PubMed ID: 35892568
[TBL] [Abstract][Full Text] [Related]
39. FTO demethylates m6A modifications in CDKAL1 mRNA and promotes gastric cancer chemoresistance by altering mitochondrial dynamics.
Liu N; Liu C; Wang Z; Wang L; Wang J; Kong J
Clin Exp Pharmacol Physiol; 2023 Apr; 50(4):307-315. PubMed ID: 36628934
[TBL] [Abstract][Full Text] [Related]
40. M6A RNA Methylation-Based Epitranscriptomic Modifications in Plasticity-Related Genes via miR-124-C/EBPα-FTO-Transcriptional Axis in the Hippocampus of Learned Helplessness Rats.
Roy B; Ochi S; Dwivedi Y
Int J Neuropsychopharmacol; 2022 Dec; 25(12):1037-1049. PubMed ID: 36161325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
